Business Name: |
Chavalithamron Suttisak MD |
Contact Person: |
Suttisak Chavalithamron |
Address: |
547 West Lancaster Boulevard, Lancaster, California 93534 |
Phone Number: |
(661) 729-8655 |
Annual Revenue (USD): |
$500.000 to $999.999 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
6211110 |
Share This Business: |
|
Related Businesses: |
Schwartz Gina MD - Lancaster, CA 93534 G.B. Ha'Eri, M.D. - Lancaster, CA 93534 Shah Nitin A MD - Lancaster, CA 93534 Sulton Barry MD - Lancaster, CA 93534 Sampson Reginald MD - Lancaster, CA 93534 Hasler Gloria L MD - Lancaster, CA 93534 Kodel Gary S MD - Lancaster, CA 93534 Rostami Khodam MD - Lancaster, CA 93534 Teget Bruce R MD - Lancaster, CA 93534 Nathan Shan A MD - Lancaster, CA 93534 Ernest Antony C MD - Lancaster, CA 93534 Vazirani Maya M MD - Lancaster, CA 93534 Compean Silvia N MD - Lancaster, CA 93534 Zambetti John MD - Lancaster, CA 93534 Munassi Dominick T MD - Lancaster, CA 93534 Nguyen Tay H MD - Lancaster, CA 93534 Tabrizi Mohsen MD - Lancaster, CA 93534 Lipel Vadim MD - Lancaster, CA 93534 Farrukh Abdallah S MD - Lancaster, CA 93534 Shah Apurva V MD - Lancaster, CA 93534 |
The company Chavalithamron Suttisak MD provides B2C services in the form of Doctors from its single location in California.
1 to 4 employees work for Chavalithamron Suttisak MD, and the business now earns $500.000 to $999.999 per annum.
Chavalithamron Suttisak MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Chavalithamron Suttisak MD, please call Suttisak Chavalithamron with the phone number (661) 729-8655 or visit its single location at 547 West Lancaster Boulevard in Lancaster, California 93534.
The location of the single location can also be found using the coordinates 34.69833,-118.13858.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.